Zinc elevates neuropeptide Y levels in rat pheochromocytoma cells by a mechanism independent of L-channel mediated inhibition of release

Brain Research

Volumn 877, Issue 1, 2000, Pages 12-22

  Schwartz, Paul J ^a,b   Grote, Sara K ^a   Stephans, Kevin L ^a   Adler, E M ^a  

^a WILLIAMS COLLEGE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Acetylcholinesterase; Dihydropyridine; Epilepsy; Feeding behavior; Neuropeptide Y; PC12 cell; Zinc

Indexed keywords

ACETYLCHOLINESTERASE; CALCIUM CHANNEL; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NEUROTRANSMITTER; ZINC;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; FEEDING BEHAVIOR; HIPPOCAMPUS; NERVE CONDUCTION; NERVE FIBER GROWTH; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEIZURE;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; NEURITES; NEUROPEPTIDE Y; NIFEDIPINE; PC12 CELLS; RATS; ZINC;

EID: 0034665835     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02645-7     Document Type: Article

References (60)

1. Adler E.M., Fink J.S. Regulation of vasoactive intestinal polypeptide gene expression by calcium influx. Soc. Neurosci. Abst. 17:1991;381.
2. Adler E.M., Fink J.S. Calcium regulation of vasoactive intestinal polypeptide mRNA abundance in SHSY5Y human neuroblastoma cells. J. Neurochem. 61:1993;727-737.
3. Allen J.M., Tischler A.S., Lee Y.C., Bloom S.R. Neuropeptide Y (NPY) in PC12 phaeochromocytoma cultures: responses to dexamethasone and nerve growth factor. Neurosci. Lett. 46:1984;291-296.
4. Allen J.M., Martin J.B., Heinreich G. Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: a model for developmental regulation. Brain Res. 427:1987;39-43.
5. Allen J.M., Koenig J.I. Central and peripheral significance of neuropeptide Y and related peptides. Ann. New York Acad. Sci. 611:1990;1-530.
6. Akabayashi A., Wahlestedt C., Alexander J.T., Leibowitz S.F. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Res. Mol. Brain Res. 21:1994;55-61.
7. Akaike N., Kostyuk P.G., Osipchuk Y.V. Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurons. J. Physiol. 412:1989;181-195.
8. Anikstejn L., Charton G., Ben-Ari Y. Selective release of endogenous zinc from the hippocampal mossy fibers in situ. Brain Res. 404:1987;58-64.
9. 2+ from brain tissue during activity. Nature. 308:1984;734-736.
10. Atar D., Backx P.H., Appel M.M., Gao W.D., Marban E. Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels. J. Biol. Chem. 270:1995;2473-2477.
11. Bendotti C., Vezzani A., Serafini R., Servadio A., Rivolta R., Samanin R. Increased preproneuropeptide Y mRNA in the rat hippocampus during the development of hippocampal kindling: comparison with the expression of preprosomatostatin mRNA. Neurosci. Lett. 132:1991;175-178.
12. 2+) blocks voltage-gated calcium channels in cultured rat dorsal root ganglion cells. Brain Res. 593:1992;77-81.
13. 2+ in the hippocampal mossy fiber zone of the rat in situ. Exp. Brain Res. 58:1985;202-205.
14. Chesters J.K., Quarterman J. Effects of zinc deficiency on food intake and feeding patterns of rats. Br. J. Nutr. 24:1970;1061-1069.
15. Choi D.W., Koh J.K. Zinc and brain injury. Annu. Rev. Neurosci. 21:1998;347-375.
16. 2+) in the brains of epileptogenic and normal mice. Brain Res. 280:1983;323-334.
17. Colmers W.F., Wahlestedt C. The Biology of Neuropeptide Y and Related Peptides. 1993;Humana Press, Totawa, NJ. 554 pp.
18. 2 and other receptors inhibit synaptic excitation in epileptic human brain. Epilepsia. 38:(Suppl. 8):1997;12.
19. De Lanerolle N.C., Kim J.H., Robbins R.J., Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495:1989;387-395.
20. Diebler H., Eigen M., Ilgenfritz G., Maas G., Winkler R. Kinetics and mechanisms of reactions of main group metal ions with biological carriers. Pure Appl. Chem. 20:1969;93-115.
21. Ellman G.L., Courtney D., Andres V., Featherstone R. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;85-95.
22. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 231:1996;415-418.
23. Fredrickson C.J., Hernandez M.D., Goik S.A., Morton J.D., McGinty J.F. Loss of zinc staining from mossy fibers during kainic acid induced seizures. Brain Res. 446:1988;383-386.
24. Gall C.M. Regulation of brain neurotrophin expression by physiological activity. Trends Pharmacol. Sci. 13:1992;401-403.
25. Greene L.A., Tischler A.S. PC12 phaeochromocytoma cells in neurobiological research. Adv. Cell. Neurobiol. 3:1982;373-414.
26. Higuchi H., Yang H.Y., Sabol S.L. Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP and phorbol ester. J. Biol. Chem. 263:1988;6288-6295.
27. 2+/calmodulin-dependent transcriptional activation of neuropeptide Y gene induced by membrane depolarization: determination of Ca(2+)- and cyclic AMP/phorbol 12-myristate 13-acetate-responsive elements. J. Neurochem. 66:1996;1802-1809.
28. Kongsamut S., Miller R.J. Nerve growth factor modulates the release and drug sensitivity of neurotransmitter release from PC12 cells. Proc. Natl. Acad. Sci. USA. 83:1986;2243-2247.
29. Lee R.G., Rains T.M., Tovar-Palacio C., Beverly J.L., Shay N.F. Zinc deficiency increases hypothalamic neuropeptide Y and neuropeptide Y mRNA levels and does not block neuropeptide Y-induced feeding. J. Nutr. 128:1998;1218-1223.
30. Marksteiner J., Ortler M., Bellmann R., Sperk G. Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy in the rat. Neurosci. Lett. 112:1990;143-148.
31. May V., Brandenburg C.A., Braas K.M. Differential regulation of sympathetic neuron neuropeptide Y and catecholamine content and secretion. J. Neurosci. 15:1995;4580-4591.
32. Mody I., Miller J.J. Levels of hippocampal calcium and zinc following kindling-induced epilepsy. Can. J. Physiol. Pharmacol. 63:1985;159-161.
33. Morgan J.I., Curran T. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol. Sci. 12:1991;343-349.
34. Nguyen T.V., Kobierski L., Comb M., Hyman S.E. The effects of depolarization on expression of the human proenkephalin gene is synergistic with cAMP and dependent upon a cyclicAMP-inducible enhancer. J. Neurosci. 10:1990;2825-2833.
35. Nawa H., Pelleymounter M.A., Carnahan J. Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14:1994;3751-3765.
36. Pitkanen A., Beal M.F., Sirvio J., Mannisto P.T., Riekkinen P.J. Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brains of pentylenetetrazol-kindled rats. Neuropeptides. 14:1989;197-207.
37. Plummer M.R., Logothetis D.E., Hess P. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron. 2:1989;1453-1463.
38. 2+ entry. J. Neurosci. 17:1997;8169-8177.
39. Rains Y.M., Hedrick S., Randall A.C., Lee R.G., Kennedy K.J., Shay N.F. Food intake patterns are altered during long-term zinc deficiency in rats. Physiol. Behav. 65:1998;473-478.
40. 3H] dopamine release in undifferentiated and differentiated PC12 cells. Neurochem. Int. 17:1990;197-203.
41. Reber B.F.X., Reuter H. Dependence of cytosolic calcium in differentiating rat pheochromocytoma cells on calcium channels and intracellular stores. J. Physiol. 435:1991;145-162.
42. Rieger F., Shelanski M.L., Greene L.A. The effects of NGF on acetylcholinesterase and its multiple forms in cultures of rat phaeochromocytoma cells: Increased total specific activity and appearance of the 16S molecular form. Dev. Biol. 76:1980;238-243.
43. Ross G.M., Shamovsky I.L., Lawrance G., Solc M., Dostaler S.M., Jimmo S.L., Weaver D.F., Riopelle R.J. Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins. Nat. Med. 3:1997;872-878.
44. Sanacora G., Kershaw M., Finkelstein J.A., White J.D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 127:1990;730-737.
45. Scharfman H.E., Goodman J.H., Sollas A.L. Actions of brain-derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus. J. Neurosci. 19:1999;5619-5631.
46. Selvais P.L., Labuche C., Nguyen X.N., Ketelslegers J.M., Denef J.F., Maiter D.M. Cyclic feeding behaviour and changes in hypothalamic galanin and neuropeptide Y gene expression induced by zinc deficiency in the rat. J. Neuroendocrinol. 9:1997;55-62.
47. Sheng M., McFadden G., Greenberg M.E. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron. 4:1990;571-582.
48. Sloviter R.S. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation. Brain Res. 330:1985;150-153.
49. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental staus epilepticus in the rat: the 'dormant basket cell' hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus. 1:1991;41-66.
50. Stanley B.G. Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance. Colmers W.F., Wahlestadt C. The Biology of Neuropeptide Y and Related Peptides. 1993;457-509 Humana Press, Totawa, NJ.
51. Stephens T.W., Basinski M., Bristow P.K., Bue-Valleskey J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Kriauciunas A., MacKeller W., Rosteck P.R., Schoner B., Smith D., Tinsley F.C., Zhang X.-Y., Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
52. Takeda A., Sawashita J., Okada S. Localization in rat brain of the trace metals, zinc and manganese, after intracerebroventricular injection. Brain Res. 658:1994;252-254.
53. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
54. Tonder N., Kragh J., Finsen B.R., Bolwig T.G., Zimmer J. Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia. 35:1994;1299-1308.
55. Vezzani A., Ravizza T., Moneta D., Conti M., Borroni A., Rizzi M., Samanin R., Maj R. Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: temporal evolution of changes as compared to neuropeptide Y. Neuroscience. 90:1999;1445-1461.
56. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:1999;25-30.
57. Walter M.J., Scherrer J.F., Flood J.F., Morley J.E. Effects of localized injections of Neuropeptide Y antibody on motor activity and other behaviors. Peptides. 15:1994;607-613.
58. Waschek J.A., Pruss R.M., Siegel R.E., Eiden L.E., Bader M.-F., Aunis D. Regulation of enkephalin, VIP and chromagranin biosynthesis in actively secreting chromaffin cells: multiple strategies for multiple peptides. Ann. New York Acad. Sci. 594:1987;104-119.
59. Wright D.M. Effect of zinc on neuronal activity in the rat forebrain. Adv. Exp. Med. Biol. 203:1986;599-609.
60. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular Neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 133:1993;1753-1758.